Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$651M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$622M |
| 3 |
Merck
MRK
|
+$496M |
| 4 |
Adobe
ADBE
|
+$446M |
| 5 |
CRH
CRH
|
+$410M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.33B |
| 2 |
Microsoft
MSFT
|
+$965M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$542M |
| 4 |
NVIDIA
NVDA
|
+$522M |
| 5 |
Linde
LIN
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.03% |
| 2 | Technology | 8.55% |
| 3 | Healthcare | 6.96% |
| 4 | Financials | 6.02% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4926
El Pollo Loco
LOCO
$463M
| $344K | ﹤0.01% |
35,331
-26,477
| -43% | -$238K |
|
4927
CALL
Alnylam Pharmaceuticals
ALNY
$31.7B
| $344K | ﹤0.01% |
2,300
-3,800
| -62% | -$634K |
|
4928
Target Hospitality
TH
$1.89B
| $344K | ﹤0.01% |
31,614
+14,214
| +82% | +$133K |
|
4929
PUT
Cameco
CCJ
$46.3B
| $342K | ﹤0.01% |
7,900
-278,700
| -97% | -$12.2M |
|
4930
Polestar Automotive Holding UK
PSNY
$1.81B
| $341K | ﹤0.01% |
7,389
+2,358
| +47% | +$128K |
|
4931
CALL
Edison International
EIX
$28.4B
| $340K | ﹤0.01% |
+4,800
| New | +$328K |
|
4932
Instil Bio
TIL
$53.3M
| $339K | ﹤0.01% |
31,381
-18,356
| -37% | -$201K |
|
4933
CALL
monday.com
MNDY
$4.21B
| $339K | ﹤0.01% |
1,500
-24,300
| -94% | -$5.16M |
|
4934
Bausch + Lomb
BLCO
$6.12B
| $339K | ﹤0.01% |
19,574
-18,379
| -48% | -$285K |
|
4935
CALL
Synchrony
SYF
$26B
| $336K | ﹤0.01% |
7,800
-19,100
| -71% | -$761K |
|
4936
CALL
Xylem
XYL
$26.3B
| $336K | ﹤0.01% |
+2,600
| New | +$314K |
|
4937
CALL
iShares MSCI South Korea ETF
EWY
$28.3B
| $336K | ﹤0.01% |
+5,000
| New | +$317K |
|
|
SBDS
4938
DELISTED
Solo Brands Inc
SBDS
| $335K | ﹤0.01% |
3,864
+2,175
| +129% | +$250K |
|
4939
PUT
Option Care Health
OPCH
$3.59B
| $335K | ﹤0.01% |
+10,000
| New | +$324K |
|
|
JKS
4940
PUT
JinkoSolar
JKS
$708M
| $335K | ﹤0.01% |
13,300
-23,900
| -64% | -$656K |
|
4941
CALL
ALX Oncology
ALXO
$283M
| $335K | ﹤0.01% |
30,000
-11,600
| -28% | -$163K |
|
4942
Boston Omaha
BOC
$415M
| $334K | ﹤0.01% |
21,622
+1,150
| +6% | +$18.1K |
|
|
AVB
4943
CALL
DELISTED
AvalonBay Communities
AVB
| $334K | ﹤0.01% |
1,800
-54,200
| -97% | -$9.75M |
|
4944
iShares Residential and Multisector Real Estate ETF
REZ
$859M
| $334K | ﹤0.01% |
+4,633
| New | +$327K |
|
4945
CALL
Gartner
IT
$12.4B
| $334K | ﹤0.01% |
+700
| New | +$322K |
|
|
4946
PUT
Gartner
IT
$12.4B
| $334K | ﹤0.01% |
+700
| New | +$322K |
|
4947
Barings BDC
BBDC
$982M
| $334K | ﹤0.01% |
+35,874
| New | +$327K |
|
4948
Greenlight Captial
GLRE
$503M
| $333K | ﹤0.01% |
26,686
+10,303
| +63% | +$120K |
|
4949
CALL
Braze
BRZE
$3.84B
| $332K | ﹤0.01% |
+7,500
| New | +$405K |
|
4950
PUT
DigitalOcean
DOCN
$14.3B
| $332K | ﹤0.01% |
8,700
-41,300
| -83% | -$1.53M |
|
Similar funds
Israel Englander's Q1 2024 Portfolio in Review
As of Q1 2024, Israel Englander held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander's Q1 2024 filing shows 858 new, 2,292 increased, 2,484 reduced and 745 closed positions. Its largest new stake was iShares Bitcoin Trust: 20,859,447 shares worth $844M. The largest sale was iShares Core S&P 500 ETF, an estimated $4.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
- Israel Englander added most to Merck in Q1 2024, an estimated $496M increase.
- Israel Englander's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
- Israel Englander fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
- Israel Englander's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
- Israel Englander opened 858 new positions and closed 745 in Q1 2024.
- Israel Englander's portfolio value rose 1.3% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.